Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
14 Mar 2007 Enzo Therapeutics Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections
09 Mar 2007 La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
09 Mar 2007 TOPIGEN Initiates Expanded Phase II Trial of Inhaled TPI ASM8 in Patients With Asthma
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
02 Mar 2007 AVI BioPharma Presents Novel HIV Drug Candidate Results
01 Mar 2007 Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
01 Mar 2007 IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
24 Feb 2007 Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
21 Feb 2007 Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
20 Feb 2007 Skin graft substitute (ICX-SKN) commences Phase I
15 Feb 2007 BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
15 Feb 2007 Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
14 Feb 2007 Neuralstem Inc. Cells Survive and Become Neurons in Rats With Spinal Injuries, Study Reports
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
13 Feb 2007 Targeted Genetics Provides Inflammatory Arthritis Clinical Trial Update
09 Feb 2007 Pluristem Announces US FDA Acceptance of its Pre-IND Application to begin Pre-clinical Studies using PLX- I in Hematological Malignancies
07 Feb 2007 ViaCell Announces CB001 Phase I Results
07 Feb 2007 Genta Announces the Company Will Appeal FDA Action on New Drug Application of Genasense(R) in Chronic Lymphocytic Leukemia
06 Feb 2007 Antisense Therapeutics Extends its Drug Discovery and Development Collaboration with Isis Pharmaceuticals
06 Feb 2007 SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-801i in Age-Related Macular Degeneration (AMD)
03 Feb 2007 Genta Completes Response to EMEA List of Outstanding Issues for Genasense® Marketing Authorization Application in Melanoma
02 Feb 2007 Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
30 Jan 2007 LCT to start clinical trial of type 1 diabetes treatment
30 Jan 2007 Advanced Viral Begins Phase II Dermatological Study
26 Jan 2007 Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application
25 Jan 2007 Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
23 Jan 2007 Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
23 Jan 2007 iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema
19 Jan 2007 Targeted Genetics Announces Publication of Inflammatory Arthritis Study in Molecular Therapy
18 Jan 2007 Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
18 Jan 2007 Studies Show Geron's Stem Cell Therapeutic For Spinal Cord Injury Produces Nerve Growth Factors
18 Jan 2007 Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
17 Jan 2007 Gentium Receives Orphan Drug Designation from FDA for Defibrotide to Prevent Hepatic Veno-occlusive Disease
16 Jan 2007 Osiris Therapeutics Receives European Orphan Drug Designation for PROCHYMAL
13 Jan 2007 ReNeuron provides a further update on the IND application for ReN001
12 Jan 2007 Takara Bio Obtains Clinical Trial Approval of Gene Therapy Treatment for Chronic Granulomatosis
12 Jan 2007 Genvec Receives Clearance From FDA For Eus Administration Of TNFerade
12 Jan 2007 Ark Holds Positive End of Phase II Meeting with FDA on Trinam(R) Gene Therapy
10 Jan 2007 Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
10 Jan 2007 Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
09 Jan 2007 ProNAi Announces Dna Interference (DNAI(R)) Drug Development Strategy For 2007
09 Jan 2007 Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn’s Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
06 Jan 2007 Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
04 Jan 2007 Archemix Announces Initiation of Phase I Clinical Trial for Novel, Selective Anti-Platelet Aptamer (ARC1779)
03 Jan 2007 Amorcyte Cardiac Cell Therapy Trial Passes First Stage and Opens Two New Sites
22 Dec 2006 Isis Development Partner iCo Therapeutics Files IND for Antisense Drug to Treat Eye Disease
20 Dec 2006 GenVec Announces Efficacy Update in Phase II/III Clinical Trial of TNFerade in Locally Advanced Pancreatic Cancer
15 Dec 2006 GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade in Pancreatic Cancer
14 Dec 2006 MicroIslet Holds Positive Pre-IND Meeting With FDA
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 594

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics